Cargando…

Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy

BACKGROUND: Predicting the long-term prognosis of individuals who experienced sorafenib treatment following partial hepatectomy due to hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is difficult. This work aims to create an effective prognostic nomogram for HBV related HCC patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Wei, Yan, Kai, Yu, Hua, Huo, Lei, Xian, Zhihong, Zhao, Yanqing, Li, Jutang, Zhang, Yuchan, Cao, Zhenying, Fu, Yong, Cong, Wenming, Dong, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906076/ https://www.ncbi.nlm.nih.gov/pubmed/33643907 http://dx.doi.org/10.3389/fonc.2020.605057

Ejemplares similares

CT-Based Radiomics Nomogram Improves Risk Stratification and Prediction of Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy
por: Wu, Cuiyun, et al.
Publicado: (2022)

The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma
por: Xie, Gui-Lin, et al.
Publicado: (2023)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
por: Wei, Meng-Chao, et al.
Publicado: (2022)

A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2021)

A Novel Nomogram for Predicting Postoperative Liver Failure After Major Hepatectomy for Hepatocellular Carcinoma
por: Lei, Zhengqing, et al.
Publicado: (2022)

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
por: Li, J, et al.
Publicado: (2014)

Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy
por: Lu, Yang, et al.
Publicado: (2023)

Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy
por: Zhang, Wei, et al.
Publicado: (2017)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers
por: Hu, Zili, et al.
Publicado: (2022)

Developing and validating a nomogram based on skeletal muscle index and clinical scoring system for prediction of liver failure after hepatectomy
por: Ding, Cong, et al.
Publicado: (2023)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
por: Zhang, Li-xiang, et al.
Publicado: (2021)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients
por: Fang, Tongdi, et al.
Publicado: (2021)

Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020)

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
por: Zheng, Jia, et al.
Publicado: (2022)

Association of preoperative albumin–bilirubin with surgical textbook outcomes following laparoscopic hepatectomy for hepatocellular carcinoma
por: Xu, Fei-Qi, et al.
Publicado: (2022)

Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy()()
por: Zhang, Jing-Ping, et al.
Publicado: (2015)

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy
por: Wang, Yifei, et al.
Publicado: (2019)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2020)

Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
por: He, Ziming, et al.
Publicado: (2023)

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
por: Pan, Yang-Xun, et al.
Publicado: (2019)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022)

Laparoscopic repeat hepatectomy versus conventional open repeat hepatectomy for recurrent hepatocellular carcinoma: A systematic review and meta-analysis
por: Hao, Fulong, et al.
Publicado: (2022)

Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
por: Liu, Lixing, et al.
Publicado: (2020)

Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis
por: Zou, YuChi, et al.
Publicado: (2022)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Dose–Response Between Serum Prealbumin and All-Cause Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma
por: Huo, Rong-Rui, et al.
Publicado: (2021)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
por: Zhou, Qunfang, et al.
Publicado: (2020)

Predictors of Spontaneous Rupture of Hepatocellular Carcinoma and Clinical Outcomes Following Hepatectomy
por: Chen, Yiran, et al.
Publicado: (2022)

Impact of metabolic syndrome on the long-term prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy
por: Zhang, Kang-Jun, et al.
Publicado: (2022)

Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2019)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rl6re3g9fav496jg28sqfds3su